Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Antibodies
Filter     Order     Display # 
Date Item Title
20 Oct 2006 FDA Expands REMICADE® (Infliximab) Indication For Ulcerative Colitis: Biologic Maintains Long-Term Clinical Remission And Mucosal Healing
19 Oct 2006 Genmab Hosts Research, Development And Business Update
18 Oct 2006 CAT And MSM Protein Technologies Enter Drug Discovery Collaboration In The Field Of Multi-Spanning Membrane Proteins
17 Oct 2006 Cambridge Antibody Technology And Debiopharm Enter Into An Exclusive Agreement To Develop And Market SC-1 For Gastric Cancer
17 Oct 2006 WILEX successfully completes Phase II study with RENCAREX(R) in combination with Interferon
17 Oct 2006 Medarex and PharmAthene Announce Phase I Results of Anthrax Therapeutic Valortim(TM)
14 Oct 2006 Roche files Herceptin plus hormonal therapy for advanced HER2-positive breast cancer with European Authorities
13 Oct 2006 Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
12 Oct 2006 FDA Approves Avastin in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
11 Oct 2006 Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with Centocor Research and Development, Inc.
11 Oct 2006 MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
11 Oct 2006 OPi and Vaccinex announce license of fully human anti-IL6 antibody
10 Oct 2006 REMICADE Receives EU Approval as Second-Line Therapy for Patients with Crohn's Disease
10 Oct 2006 OMRIX Biopharmaceuticals Enters into a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop Antibody-Based Therapeutics for the Treatment of Influenza
06 Oct 2006 New Phase III Data Show Abbott's HUMIRA ® (adalimumab) was Statistically Superior to Methotrexate in Patients with Psoriasis
06 Oct 2006 MacroGenics' Novel Monoclonal Antibody Shows Potent Anti-tumor Activity Against B-Cell Lymphoma in Preclinical Studies
06 Oct 2006 Schering AG and Biogen Idec announce start of the “ZEAL” Phase III Clinical Trial with anti-cancer drug Zevalin
05 Oct 2006 New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration
05 Oct 2006 ImmunoGen Announces Initiation of Clinical Testing of AVE1642 Anticancer Compound in Collaboration with sanofi-aventis
04 Oct 2006 InNexus Biotechnology Announces Collaboration Focused on Developing Novel Antiviral Antibodies
04 Oct 2006 XOMA to Humanize Attenuon's Novel Anti-Cancer Antibody
03 Oct 2006 Avantogen Oncology Inc. Files IND Application for RP101
03 Oct 2006 XOMA and Affimed Sign Antibody Cross-License and Collaboration Agreement
02 Oct 2006 Final Data From Two Phase II Trials Indicate Activity Of Adecatumumab (MT201) In Breast And Prostate Cancer
30 Sep 2006 Human Genome Sciences Reports Positive Results Of Phase 1 Clinical Trial Of CCR5 mAB In Patients Infected With HIV-1
30 Sep 2006 FDA Approves Two New Indications for Rituxan in Patients With Non-Hodgkin’s Lymphoma
30 Sep 2006 New Data Presented at ECTRIMS Congress Show TYSABRI® Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
30 Sep 2006 New Data Presented at ECTRIMS Congress Show TYSABRI® Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
29 Sep 2006 Elusys Presents Positive Data on Anthrax Therapeutic at ICAAC
29 Sep 2006 New Data on TYSABRI® Presented at ECTRIMS Congress Demonstrate Significant Improvement in Cognitive Function in Patients with Multiple Sclerosis
28 Sep 2006 FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
28 Sep 2006 Trubion Announces Initiation of Phase IIb Clinical Trial of TRU-015 for the Treatment of Rheumatoid Arthritis
28 Sep 2006 FDA Approves REMICADE® (Infliximab) For Treatment Of Chronic Severe Plaque Psoriasis: Marks Major Milestone For Patients With High Disease Burden
28 Sep 2006 InNexus Enters R&D Agreement Targeting Cancer with BioInvent of Sweden; Appoints New Chairman of the Board of Directors
27 Sep 2006 Alexion Submits Market Authorization Application for Soliris(TM) (eculizumab) in the Treatment of Paroxysmal Nocturnal Hemoglobinuria to the European Medicines Agency
23 Sep 2006 Genmab Completes Accrual in HuMax-CD20 Phase II RA Study
21 Sep 2006 Alexion Pharmaceuticals Submits Biologics License Application for Soliris(tm) (eculizumab)
21 Sep 2006 Soliris™ (eculizumab) Demonstrates Significant Improvement in PNH Study
20 Sep 2006 Amgen Presents Denosumab and Sclerostin Antibody Data at American Society for Bone and Mineral Research Annual Meeting; Data Suggest the Potential for Targeting the Key Proteins, RANK Ligand and Sclerostin, for Bone Loss Conditions
20 Sep 2006 Researchers Report Peregrine's Phospholipid-Targeted Antibodies Fused With Cytokines Reduce Tumor Growth in Animals by Over 90%
20 Sep 2006 Caprion Announces Completion of Phase I Clinical Studies for its Shigatoxin-producing E. coli Therapy
15 Sep 2006 Genzyme Reports Interim Results from Trial of Campath(R) for Multiple Sclerosis
14 Sep 2006 Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head And Neck Cancer
12 Sep 2006 Genentech Receives Complete Response Letter From FDA for Avastin in Metastatic Breast Cancer
12 Sep 2006 Peregrine to Initiate Bavituximab Combination Therapy Trial in India With Multiple Cancer Chemotherapy Regimens
12 Sep 2006 New data explain cancer cell killing by AS1402
08 Sep 2006 Abbott Submits U.S. and E.U. Regulatory Applications Seeking Approval for HUMIRA® (adalimumab) as a Treatment for Crohn's Disease
08 Sep 2006 GlycoFi and Dartmouth Report Full Humanization of Yeast Glycosylation Pathway in Science; Availability of Engineered Yeast Strains Could Eliminate the Need for Mammalian Cell Culture and Offer Opportunities for Improving Therapeutic Proteins
07 Sep 2006 Medarex and Massachusetts Biologic Laboratories Announce Commencement of Phase II Clinical Trial of Anti-C. difficile Antibody Combination for the Treatment of Hospital Acquired Diarrhea
05 Sep 2006 Protherics Plc announces Publication of CytoFab(R) Phase 2b Data in Leading Journal
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>
Results 851 - 900 of 1155

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics